Статья

Immunogenicity and protective efficacy of influenza a DNA vaccines encoding artificial antigens based on conservative hemagglutinin stem region and M2 protein in mice

S. Bazhan, D. Antonets, E. Starostina, T. Ilyicheva, O. Kaplina, V. Marchenko, A. Durymanov, S. Oreshkova, L. Karpenko,
2021

Background: Development of a universal vaccine capable to induce antibody responses against a broad range of influenza virus strains attracts growing attention. Hemagglutinin stem and the exposed fragment of influenza virus M2 protein are promising targets for induction of cross-protective humoral and cell-mediated response, since they contain conservative epitopes capable to induce antibodies and cytotoxic T lymphocytes (CTLs) to a wide range of influenza virus subtypes. Methods: In this study, we generated DNA vaccine constructs encoding artificial antigens AgH1, AgH3, and AgM2 designed on the basis of conservative hemagglutinin stem fragments of two influenza A virus subtypes, H1N1 and H3N2, and conservative M2 protein, and evaluate their immunogenicity and protective efficacy. To obtain DNA vaccine constructs, genes encoding the designed antigens were cloned into a pcDNA3.1 vector. Expression of the target genes in 293T cells transfected with DNA vaccine constructs has been confirmed by synthesis of specific mRNA. Results: Immunization of BALB/c mice with DNA vaccines encoding these antigens was shown to evoke humoral and T-cell immune responses as well as a moderated statistically significant cross-protective effect against two heterologous viruses A/California/4/2009 (H1N1pdm09) and A/Aichi/2/68 (H3N2). Conclusions: The results demonstrate a potential approach to creating a universal influenza vaccine based on artificial antigens. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • S. Bazhan
    Theoretical Department, State Research Center of Virology and Biotechnology “Vector”, Novosibirsk Region, Koltsovo, 630559, Russian Federation
  • D. Antonets
    Bioengineering Department, State Research Center of Virology and Biotechnology “Vector”, Novosibirsk Region, Koltsovo, 630559, Russian Federation
  • E. Starostina
    Department of Zoonotic Infections and Influenza, State Research Center of Virology and Biotechnology “Vector”, Novosibirsk Region, Koltsovo, 630559, Russian Federation
  • T. Ilyicheva
  • O. Kaplina
  • V. Marchenko
  • A. Durymanov
  • S. Oreshkova
  • L. Karpenko
Название журнала
  • Vaccines
Том
  • 8
Выпуск
  • 3
Страницы
  • 1-17
Ключевые слова
  • chimeric antigen receptor; DNA vaccine; epitope; gamma interferon; hemagglutinin; influenza vaccine; membrane protein; messenger RNA; neutralizing antibody; protein M2; amino acid sequence; animal cell; animal experiment; animal model; antibody dependent cellular cytotoxicity; antigen structure; Article; controlled study; cytosolic fraction; cytotoxic T lymphocyte; DNA immunization; enzyme linked immunosorbent assay; enzyme linked immunospot assay; gene construct; gene expression; gene frequency; gene mutation; genetic transfection; genetic variability; HEK293T cell line; immunization; immunogenicity; influenza; LD50; molecular cloning; mouse; nonhuman; nucleotide sequence; plasmid; real time polymerase chain reaction; RNA isolation; Sanger sequencing; sequence analysis; signal transduction; T lymphocyte; vaccination; virus neutralization
Издатель
  • MDPI AG
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus